These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21417215)

  • 1. Stereoselective synthesis of MLN4924, an inhibitor of NEDD8-activating enzyme.
    Lee HW; Nam SK; Choi WJ; Kim HO; Jeong LS
    J Org Chem; 2011 May; 76(9):3557-61. PubMed ID: 21417215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a NEDD8-AMP mimetic in situ.
    Brownell JE; Sintchak MD; Gavin JM; Liao H; Bruzzese FJ; Bump NJ; Soucy TA; Milhollen MA; Yang X; Burkhardt AL; Ma J; Loke HK; Lingaraj T; Wu D; Hamman KB; Spelman JJ; Cullis CA; Langston SP; Vyskocil S; Sells TB; Mallender WD; Visiers I; Li P; Claiborne CF; Rolfe M; Bolen JB; Dick LR
    Mol Cell; 2010 Jan; 37(1):102-11. PubMed ID: 20129059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.
    Luo Z; Yu G; Lee HW; Li L; Wang L; Yang D; Pan Y; Ding C; Qian J; Wu L; Chu Y; Yi J; Wang X; Sun Y; Jeong LS; Liu J; Jia L
    Cancer Res; 2012 Jul; 72(13):3360-71. PubMed ID: 22562464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy.
    Nawrocki ST; Griffin P; Kelly KR; Carew JS
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1563-73. PubMed ID: 22799561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A natural product-like inhibitor of NEDD8-activating enzyme.
    Leung CH; Chan DS; Yang H; Abagyan R; Lee SM; Zhu GY; Fong WF; Ma DL
    Chem Commun (Camb); 2011 Mar; 47(9):2511-3. PubMed ID: 21240405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924.
    Blank JL; Liu XJ; Cosmopoulos K; Bouck DC; Garcia K; Bernard H; Tayber O; Hather G; Liu R; Narayanan U; Milhollen MA; Lightcap ES
    Cancer Res; 2013 Jan; 73(1):225-34. PubMed ID: 23100467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MLN4924, a First-in-Class NEDD8-Activating Enzyme Inhibitor, Attenuates IFN-β Production.
    Song H; Huai W; Yu Z; Wang W; Zhao J; Zhang L; Zhao W
    J Immunol; 2016 Apr; 196(7):3117-23. PubMed ID: 26895833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.
    Huang J; Zhou Y; Thomas GS; Gu Z; Yang Y; Xu H; Tricot G; Zhan F
    Clin Cancer Res; 2015 Dec; 21(24):5532-42. PubMed ID: 26156395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad and potent antiviral activity of the NAE inhibitor MLN4924.
    Le-Trilling VT; Megger DA; Katschinski B; Landsberg CD; Rückborn MU; Tao S; Krawczyk A; Bayer W; Drexler I; Tenbusch M; Sitek B; Trilling M
    Sci Rep; 2016 Feb; 6():19977. PubMed ID: 26829401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.
    Lin JJ; Milhollen MA; Smith PG; Narayanan U; Dutta A
    Cancer Res; 2010 Dec; 70(24):10310-20. PubMed ID: 21159650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover.
    Milhollen MA; Narayanan U; Soucy TA; Veiby PO; Smith PG; Amidon B
    Cancer Res; 2011 Apr; 71(8):3042-51. PubMed ID: 21487042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication.
    Jiang Y; Jia L
    Anticancer Agents Med Chem; 2015; 15(9):1127-33. PubMed ID: 25742093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization of Human Colorectal Cancer Cells by MLN4924: An Inhibitor of NEDD8-Activating Enzyme.
    Wan J; Zhu J; Li G; Zhang Z
    Technol Cancer Res Treat; 2016 Aug; 15(4):527-34. PubMed ID: 26082455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide metabolism and augments the efficacy of cytarabine.
    Nawrocki ST; Kelly KR; Smith PG; Keaton M; Carraway H; Sekeres MA; Maciejewski JP; Carew JS
    Clin Cancer Res; 2015 Jan; 21(2):439-47. PubMed ID: 25388161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the NEDD8 inhibitor MLN4924 (Pevonedistat) in a cyclotherapy approach to protect wild-type p53 cells from MLN4924 induced toxicity.
    Malhab LJ; Descamps S; Delaval B; Xirodimas DP
    Sci Rep; 2016 Nov; 6():37775. PubMed ID: 27901050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of neddylation modification stimulates tumor sphere formation in vitro and stem cell differentiation and wound healing in vivo.
    Zhou X; Tan M; Nyati MK; Zhao Y; Wang G; Sun Y
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E2935-44. PubMed ID: 27162365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway.
    Bailly A; Perrin A; Bou Malhab LJ; Pion E; Larance M; Nagala M; Smith P; O'Donohue MF; Gleizes PE; Zomerdijk J; Lamond AI; Xirodimas DP
    Oncogene; 2016 Jan; 35(4):415-26. PubMed ID: 25867069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective synthesis of 3-hydroxymethyl-D-cyclopentenone, the versatile intermediate for the synthesis of carbocyclic nucleosides.
    Choi WJ; Moon HR; Kim HO; Ko YM; Kim HJ; Lee JA; Lee KM; Yun MK; Shin DH; Chun MW; Sheen YY; Kim K; Jeong LS
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):611-3. PubMed ID: 16247998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of SMALL ACIDIC PROTEIN 1 (SMAP1) causes increased sensitivity to an inhibitor of RUB/NEDD8-activating enzyme in Arabidopsis seedlings.
    Oono Y; Nakasone A
    Plant Signal Behav; 2013 Oct; 8(10):. PubMed ID: 24270629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-emergent mutations in NAEβ confer resistance to the NEDD8-activating enzyme inhibitor MLN4924.
    Milhollen MA; Thomas MP; Narayanan U; Traore T; Riceberg J; Amidon BS; Bence NF; Bolen JB; Brownell J; Dick LR; Loke HK; McDonald AA; Ma J; Manfredi MG; Sells TB; Sintchak MD; Yang X; Xu Q; Koenig EM; Gavin JM; Smith PG
    Cancer Cell; 2012 Mar; 21(3):388-401. PubMed ID: 22439935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.